NCT02147691View on ClinicalTrials.gov

Finacea 15% and Brimonidine 0.33% Gel in the Treatment of Rosacea - A Pilot Study

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

February 28, 2015

Conditions
Acne Rosacea
Interventions
DRUG

Azelaic acid 15%

Applied to the face each AM and PM

DRUG

Brimonidine 0.33%

Applied to the face each AM 30 minutes after the application of Azelaic acid 15%

Trial Locations (1)

40217

DermResearch, PLLC, Louisville

Sponsors
All Listed Sponsors
collaborator

Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

INDUSTRY

lead

Derm Research, PLLC

OTHER